Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Posch Florian |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2025

Originalarbeit (Zeitschrift)

** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124 Doi: 10.1002/ehf2.15221 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Schneider, N; Koellinger, M; Hatzl, S; Hackl, G; Raggam, R; von, Lewinski, D; Posch, F; Eller, P Anticoagulation Monitoring Strategies During Extracorporeal Membrane Oxygenation (ECMO) Therapy - Differences Between Simultaneously Obtained Coagulation Tests: A Retrospective Single-Center Cohort Study.
J Intensive Care Med. 2025; 8850666241313357 Doi: 10.1177/08850666241313357
Web of Science PubMed FullText FullText_MUG

 

** Rinnerthaler, G; Egle, D; Bartsch, R; Schmitt, CA; Petzer, A; Balic, M; Petru, E; Denison, U; Singer, CF; Bjelic-Radisic, V; Gampenrieder, SP; Knauer, M; Sotlar, K; Brunner, C; Posch, F; Hlauschek, D; Sölkner, L; Bago-Horvath, Z; Filipits, M; Gili, M; Ritter, M; Wieser, V; Albertini, C; Zaborsky, N; Weiss, L; Marhold, M; Schneeweiss, B; Pusch, R; Gnant, M; Greil, R Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Nat Cancer. 2025; Doi: 10.1038/s43018-024-00890-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Hatzl, S; Posch, F; Scholz, L; Geiger, C; Kriegl, L; Kreuzer, P; Eller, P; Giacobbe, DR; Bassetti, M; Hoenigl, M; Krause, R Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Clin Microbiol Infect. 2024; Doi: 10.1016/j.cmi.2024.12.024
Web of Science PubMed FullText FullText_MUG

 

2024

Originalarbeit (Zeitschrift)

** Gressenberger, P; Posch, F; Adelsmayr, G; Nagy, E; Kaufmann-Bühler, AK; Steiner, J; Janisch, M; Reiter, C; Eibisberger, M; Janek, E; Softic, N; Fuchsjäger, M; Gütl, K; Jud, P; Silbernagel, G; Raggam, RB; Brodmann, M; Gary, T; Schmid, J Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolism.
Sci Rep. 2024; 14(1): 25962 Doi: 10.1038/s41598-024-77669-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Scholz, L; Posch, F; Eller, P; Reisinger, AC; Zacharias, M; Gorkiewicz, G; Hoenigl, M; Zollner-Schwetz, I; Krause, R Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria.
Emerg Infect Dis. 2024; 30(6): 1275-1278. Doi: 10.3201/eid3006.231720 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** John, N; Schlintl, V; Sassmann, T; Lindenmann, J; Fediuk, M; Wurm, R; Douschan, P; Zacharias, M; Kalson, L; Posch, F; Absenger, G; Brcic, L; Jost, PJ; Terbuch, A Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
J Immunother Cancer. 2024; 12(4): Doi: 10.1136/jitc-2023-008592 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Wölfler, A; Reisinger, AC; Reinisch, A; Eller, P; Eisner, F; Kreuzer, P; Stradner, M; Rosenkranz, AR; Krammer, F; Schilcher, G; Krause, R; Hatzl, S Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Crit Care Explor. 2024; 6(2): e1046 Doi: 10.1097/CCE.0000000000001046 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Konjic, S; Schlintl, V; Absenger, G; Jost, PJ; Lindenmann, J; Swatek, P; John, N; John, T; Wurm, R; Zacharias, M; Posch, F; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Wolf, D; Augustin, F; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Transl Lung Cancer Res. 2024; 13(11): 3096-3105. Doi: 10.21037/tlcr-24-433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** John, N; Terbuch, A; Konjic, S; Absenger, G; Jost, PJ; Lindenmann, J; Fediuk, M; Sassmann, T; Wurm, R; Zacharias, M; Posch, F; Hochmaier, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Pircher, A; Brcic, L Prognostic impact of targetable driver alterations in resected early-stage lung cancer
WIEN KLIN WOCHENSCHR. 2024; 136(S13):S531-S531.-48. Jahrestagung ÖGP - 8th Jahrestagung OGTC; SEP 26-28, 2024; Vienna, Austria. [Poster]
Web of Science

 

2023

Originalarbeit (Zeitschrift)

** Ay, C; Grilz, E; Nopp, S; Moik, F; Königsbrügge, O; Klimek, P; Thurner, S; Posch, F; Pabinger, I Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study.
Res Pract Thromb Haemost. 2023; 7(1): 100026 Doi: 10.1016/j.rpth.2022.100026 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12): Doi: 10.1136/jitc-2023-007765 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Kriegl, L; Posch, F; Schilcher, G; Eller, P; Reisinger, A; Grinschgl, Y; Muhr, T; Meinitzer, A; Hoenigl, M; Krause, R Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2023; 78(12):2902-2908 Doi: 10.1093/jac/dkad328
Web of Science PubMed FullText FullText_MUG

 

** Leitner, L; Bratschitsch, G; Kostwein, A; Sadoghi, P; Smolle, M; Leithner, A; Posch, F More help than harm: surgery for metastatic spinal cord compression is associated with more favorable overall survival within a propensity score analysis.
Eur Spine J. 2023; 32(7):2468-2478 Doi: 10.1007/s00586-023-07755-9
Web of Science PubMed FullText FullText_MUG

 

** Posch-Pertl, L; List, W; Michelitsch, M; Pinter-Hausberger, S; Posch, F; Innauer, F; Renner, W; Weger, M Role of the ABO Blood Groups as a Risk Factor for Retinal Vein Occlusion.
Ophthalmic Res. 2023; 66(1):164-169 Doi: 10.1159/000526874
Web of Science PubMed FullText FullText_MUG

 

** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81 Doi: 10.1016/j.ejim.2023.07.027
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Andreou, D; Wölfel, J; Acem, I; Aj, Van, De, Sande, M; Jeys, L; Bonenkamp, H; Pollock, R; Tunn, PU; Haas, R; Posch, F; Van, Ginkel, RJ; Verhoef, C; Liegl-Atzwanger, B; Moustafa-Hubmer, D; Jost, PJ; Leithner, A; Szkandera, J Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models.
Radiother Oncol. 2023; 189:109944 Doi: 10.1016/j.radonc.2023.109944
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Kogler, A; Andreou, D; Scheipl, S; Bergovec, M; Castellani, C; Till, H; Benesch, M; Posch, F; Szkandera, J; Smolle-Jüttner, FM; Leithner, A Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.
Cancers (Basel). 2023; 15(6): 1733 Doi: 10.3390/cancers15061733 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Linhofer, M; Aberle, S; Zollner-Schwetz, I; Krammer, F; Krause, R Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea.
Emerg Infect Dis. 2023; 29(5): 1038-1041. Doi: 10.3201/eid2905.221625 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sadoghi, B; Posch, F; Komericki, P; Tripolt-Droschl, K; Kränke, B; Ahyai, SA; Strimitzer-Komericki, T; Hutterer, GC Pre-test probability of sexually transmitted infections in persons presenting to a STI clinic: A prospective study.
J Dtsch Dermatol Ges. 2023; Doi: 10.1111/ddg.15255
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5): [Oral Communication]
Web of Science

 

2022

Originalarbeit (Zeitschrift)

** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083 Doi: 10.1002/cam4.4675 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13:840207 Doi: 10.3389/fimmu.2022.840207 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Colling, ME; Ay, C; Kraemmer, D; Koder, S; Quehenberger, P; Pabinger, I; Posch, F; Gebhart, J Lupus anticoagulant test persistence over time and its associations with future thrombotic events.
Blood Adv. 2022; 6(10):2957-2966 Doi: 10.1182/bloodadvances.2021006011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gressenberger, P; Posch, F; Pechtold, M; Gütl, K; Muster, V; Jud, P; Riedl, J; Silbernagel, G; Kolesnik, E; Schmid, J; Raggam, RB; Brodmann, M; Gary, T Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis.
Front Cardiovasc Med. 2022; 9: 808605 Doi: 10.3389/fcvm.2022.808605 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** List, W; Weger, M; Pinter-Hausberger, S; Posch, F; Rabensteiner, J; Pailer, S; Wedrich, A; Posch-Pertl, L ENDOTHELIN-1 AS A RISK FACTOR IN RETINAL VEIN OCCLUSION.
Retina. 2022; 42(4):738-743 Doi: 10.1097/IAE.0000000000003374
Web of Science PubMed FullText FullText_MUG

 

** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353 Doi: 10.1016/j.clgc.2022.03.010
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428 Doi: 10.3389/fcvm.2022.933428 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch-Pertl, L; List, W; Michelitsch, M; Pinter-Hausberger, S; Berisha, B; Posch, F; Kloeckl, L; Renner, W; Weger, M Heme oxygenase-1 gene rs2071746 polymorphism in retinal vein occlusion.
Ophthalmic Genet. 2022; 43(5):627-632 Doi: 10.1080/13816810.2022.2092754
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463 Doi: 10.1038/s41416-021-01601-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832 Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science PubMed FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1):1-9 Doi: 10.1159/000512467 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
THROMB RES. 2022; 213: S16-S17.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY. [Poster]
Web of Science

 

** Muster, V; Raggam, RB; Urbanic-Purkart, T; Posch, F; Gutl, K; Rabensteiner, J; Pruller, F; von Campe, G; Rief, M; Brodmann, M; Gary, T LOWER-EXTREMITY DEEP VEIN THROMBOSIS AND BLEEDING COMPLICATIONS IN PRIMARY BRAIN TUMOR PATIENTS: A PROSPECTIVE STUDY
NEURO-ONCOLOGY. Meeting Abstracts. 2022; 24(S2):-17th Meeting of the European-Association-of-Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA. Doi: 10.1093/neuonc/noac174.190 [Poster]
Web of Science FullText FullText_MUG

 

** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien. [Poster]
Web of Science

 

** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322. [Poster]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR+ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400 Doi: 10.1002/1878-0261.12870 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grilz, E; Posch, F; Nopp, S; Königsbrügge, O; Lang, IM; Klimek, P; Thurner, S; Pabinger, I; Ay, C Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
Eur Heart J. 2021; 42(23): 2299-2307. Doi: 10.1093/eurheartj/ehab171
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621 Doi: 10.1097/HS9.0000000000000621 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73 Doi: 10.1186/s13613-021-00867-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Reisinger, AC; Posch, F; Prattes, J; Stradner, M; Pilz, S; Eller, P; Schoerghuber, M; Toller, W; Gorkiewicz, G; Metnitz, P; Rief, M; Prüller, F; Rosenkranz, AR; Valentin, T; Krause, R; Hoenigl, M; Schilcher, G Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Crit Care. 2021; 25(1): 335 Doi: 10.1186/s13054-021-03753-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Prager, G; Thaler, J; Posch, F; Wiedemann, S; Schramm, T; Englisch, C; Mackman, N; Pabinger, I; Ay, C Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Arterioscler Thromb Vasc Biol. 2021; 41(11): 2837-2847. Doi: 10.1161/ATVBAHA.121.316463
Web of Science PubMed FullText FullText_MUG

 

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13:17588359211039930 Doi: 10.1177/17588359211039930 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch-Pertl, L; Weger, M; Pinter-Hausberger, S; List, W; Posch, F; Wedrich, A; Michelitsch, K; Kozma, MO; Woltsche, N; Binder, CJ SERUM LEVELS OF ANTIBODIES AGAINST OXIDATION-SPECIFIC EPITOPES ARE DECREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION.
Retina. 2021; 41(6):1193-1201 Doi: 10.1097/IAE.0000000000003001
Web of Science PubMed FullText FullText_MUG

 

** Reisinger, AC; Niedrist, T; Posch, F; Hatzl, S; Hackl, G; Prattes, J; Schilcher, G; Meißl, AM; Raggam, RB; Herrmann, M; Eller, P Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Sci Rep. 2021; 11(1): 17476 Doi: 10.1038/s41598-021-96352-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Posch, F; Hackl, G; Marsche, G; Sourij, H; Bourgeois, B; Eller, K; Madl, T; Eller, P Branched-Chain Amino Acids Can Predict Mortality in ICU Sepsis Patients.
Nutrients. 2021; 13(9): Doi: 10.3390/nu13093106 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151:3-13 Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; López-García, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Oncoimmunology. 2021; 10(1):1896658 Doi: 10.1080/2162402X.2021.1896658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10): Doi: 10.3390/cancers13102492 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, EV; Posch, F; Henzinger, E; Muller, HD; Stoger, H; Dandachi, N; Balic, M Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
BREAST CARE. 2021; Doi: 10.1159/000513766 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)
BREAST CARE. 2021; Doi: 10.1159/000512467
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aramberri, M; Munoz-Guglielmetti, D; Pesantez, D; Posch, F; Ay, C; Beato, C; Diaz-Pedroche, C; Font, C Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired versus outpatient) at diagnosis in the era of incidental events
THROMB RES. 2021; 200: S53-S54. [Onlinepräsentation]
Web of Science

 

** Colling, M; Posch, F; Koder, S; Quehenberger, P; Ay, C; Pabinger, I; Gebhart, J Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant
BLOOD. 2021; 138: Doi: 10.1182/blood-2021-148365
Web of Science FullText FullText_MUG

 

** Font, C; Posch, F; Ay, C; Aramberri, M; Pesantez, D; Munoz-Guglielmetti, D; Beato, C; Diaz-Pedroche, C Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
THROMB RES. 2021; 200: S66-S67. [Onlinepräsentation]
Web of Science

 

** Moik, F; van Es, N; Posch, F; Di Nisio, M; Fureder, T; Preusser, M; Pabinger, I; Ay, C Evaluation of gemcitabine and platinum agents for the prediction of venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis Study
THROMB RES. 2021; 200: S68-S69. [Poster]
Web of Science FullText

 

** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lackner, A; Tiefenthaler, V; Mirzayeva, J; Posch, F; Rossmann, C; Kastrati, K; Radner, H; Demel, U; Gretler, J; Stotz, M; Graninger, WB; Stradner, MH The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study.
Ther Adv Musculoskelet Dis. 2020; 12: 1759720X20975907-1759720X20975907. Doi: 10.1177/1759720X20975907 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Leitner, L; Posch, F; Amerstorfer, F; Sadoghi, P; Leithner, A; Glehr, M The Dark Side of Arthroplasty: Competing Risk Analysis of Failed Hip and Knee Arthroplasty With Periprosthetic Joint Infection.
J Arthroplasty. 2020; 35(9):2601-2606 Doi: 10.1016/j.arth.2020.04.078 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Taucher, V; Pichler, M; Posch, F; Brcic, L; Smolle, E; Koter, S; Smolle, J; Smolle-Juettner, FM Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score.
Cancers (Basel). 2020; 12(1): Doi: 10.3390/cancers12010152 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mir, Seyed, Nazari, P; Berghoff, AS; Preusser, M; Moik, F; Posch, F; Ricken, G; Riedl, J; Hell, L; Marosi, C; Hainfellner, JA; Pabinger, I; Ay, C Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma.
ESMO Open. 2020; 5(3):e000647 Doi: 10.1136/esmoopen-2019-000647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
Thromb Res. 2020; 187:9-17 Doi: 10.1016/j.thromres.2020.01.002 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Posch, F; Zielinski, C; Pabinger, I; Ay, C Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials.
Res Pract Thromb Haemost. 2020; 4(4):550-561 Doi: 10.1002/rth2.12359 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; van, Es, N; Posch, F; Di, Nisio, M; Fuereder, T; Preusser, M; Pabinger, I; Ay, C Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study.
Cancers (Basel). 2020; 12(9): Doi: 10.3390/cancers12092493 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Zöchbauer-Müller, S; Posch, F; Pabinger, I; Ay, C Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer.
Cancers (Basel). 2020; 12(6): Doi: 10.3390/cancers12061619 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30 Doi: 10.1038/s41698-020-00134-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Hofer, S; Thaler, J; Hell, L; Königsbrügge, O; Grilz, E; Mauracher, LM; Gebhart, J; Marosi, C; Jilma, B; Pabinger, I; Ay, C Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.
Transl Res. 2020; 215: 41-56. Doi: 10.1016/j.trsl.2019.08.009 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Riedl, J; Reitter, EM; Crowther, MJ; Grilz, E; Quehenberger, P; Jilma, B; Pabinger, I; Ay, C Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.
J Thromb Haemost. 2020; 30 Suppl 4: Doi: 10.1111/jth.14774 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Schuller, M; Holzer, M; Stadler, JT; Hackl, G; Posch, F; Marsche, G; Sourij, H; Ekart, R; Eller, K; Eller, P Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock-A Prospective Pilot Study.
Front Med (Lausanne). 2020; 7:579677-579677 Doi: 10.3389/fmed.2020.579677 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Wöll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol. 2020; 12: 1758835919900872-1758835919900872. Doi: 10.1177/1758835919900872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438. Doi: 10.1038/s41598-020-69237-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833 Doi: 10.1007/s12253-020-00864-6
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16): Doi: 10.1158/1538-7445.AM2020-4295 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

** Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15): [Onlinepräsentation]
Web of Science FullText

 

Kommentar

** Posch, F; Hatzl, S; Ay, C Heparins as cancer therapy: in theory, they should have worked.
Lancet Haematol. 2020; 7(10): e703-e704-e703-e704. Doi: 10.1016/S2352-3026(20)30276-3
Web of Science PubMed FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gebhart, J; Posch, F; Koder, S; Quehenberger, P; Perkmann, T; Kuessel, L; Ay, C; Pabinger, I High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.
Blood Adv. 2019; 3(5): 769-776. Doi: 10.1182/bloodadvances.2018026948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grilz, E; Marosi, C; Königsbrügge, O; Riedl, J; Posch, F; Lamm, W; Lang, IM; Pabinger, I; Ay, C Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
J Thromb Haemost. 2019; 17(8): 1335-1344. Doi: 10.1111/jth.14484 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grilz, E; Mauracher, LM; Posch, F; Königsbrügge, O; Zöchbauer-Müller, S; Marosi, C; Lang, I; Pabinger, I; Ay, C Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Br J Haematol. 2019; 186(2): 311-320. Doi: 10.1111/bjh.15906 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hell, L; Ay, C; Posch, F; Gebhart, J; Koder, S; Mackman, N; Pabinger, I; Thaler, J Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
Ann Hematol. 2019; 98(2):313-319 Doi: 10.1007/s00277-018-3544-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mulder, FI; Candeloro, M; Kamphuisen, PW; Di Nisio, M; Bossuyt, PM; Guman, N; Smit, K; Büller, HR; van Es, N; CAT-prediction collaborators The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Haematologica. 2019; 104(6): 1277-1287. Doi: 10.3324/haematol.2018.209114 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283 Doi: 10.1245/s10434-019-07741-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Int J Cardiol. 2019; 282: 47-52. Doi: 10.1016/j.ijcard.2019.01.089
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.
Res Pract Thromb Haemost. 2019; 3(2): 207-216. Doi: 10.1002/rth2.12189 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081171 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Farge, D; Frere, C; Connors, JM; Ay, C; Khorana, AA; Munoz, A; Brenner, B; Kakkar, A; Rafii, H; Solymoss, S; Brilhante, D; Monreal, M; Bounameaux, H; Pabinger, I; Douketis, J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Lancet Oncol. 2019; 20(10): e566-e581-e566-e581. Doi: 10.1016/S1470-2045(19)30336-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Coronel, DSP; Guglielmetti, DM; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Font, C Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

 

** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

** Guglielmetti, DM; Pesantez, D; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Diaz-Pedroche, C; Font, C Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired vs. outpatient) at diagnosis
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE. [Poster]
Web of Science

 

** Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN. Doi: 10.1093/annonc/mdz155.285 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

2018

Originalarbeit (Zeitschrift)

** Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.
Int J Cardiol. 2018; 253: 71-77. Doi: 10.1016/j.ijcard.2017.10.110
Web of Science PubMed FullText FullText_MUG

 

** Grilz, E; Königsbrügge, O; Posch, F; Schmidinger, M; Pirker, R; Lang, IM; Pabinger, I; Ay, C Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
Haematologica. 2018; 103(9): 1549-1556. Doi: 10.3324/haematol.2018.192419 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grilz, E; Posch, F; Königsbrügge, O; Schwarzinger, I; Lang, IM; Marosi, C; Pabinger, I; Ay, C Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer.
Thromb Haemost. 2018; 118(11): 1875-1884. Doi: 10.1055/s-0038-1673401
Web of Science PubMed FullText FullText_MUG

 

** Leitner, L; Türk, S; Heidinger, M; Stöckl, B; Posch, F; Maurer-Ertl, W; Leithner, A; Sadoghi, P Trends and Economic Impact of Hip and Knee Arthroplasty in Central Europe: Findings from the Austrian National Database.
Sci Rep. 2018; 8(1): 4707-4707. Doi: 10.1038/s41598-018-23266-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mauracher, LM; Posch, F; Martinod, K; Grilz, E; Däullary, T; Hell, L; Brostjan, C; Zielinski, C; Ay, C; Wagner, DD; Pabinger, I; Thaler, J Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
J Thromb Haemost. 2018; 16(3):508-518 Doi: 10.1111/jth.13951 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mir Seyed Nazari, P; Riedl, J; Preusser, M; Posch, F; Thaler, J; Marosi, C; Birner, P; Ricken, G; Hainfellner, JA; Pabinger, I; Ay, C Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.
J Thromb Haemost. 2018; 16(6): 1121-1127. Doi: 10.1111/jth.14129 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pabinger, I; van Es, N; Heinze, G; Posch, F; Riedl, J; Reitter, EM; Di Nisio, M; Cesarman-Maus, G; Kraaijpoel, N; Zielinski, CC; Büller, HR; Ay, C A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Lancet Haematol. 2018; 5(7): e289-e298-e289-e298. Doi: 10.1016/S2352-3026(18)30063-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Partl, R; Döller, C; Riedl, JM; Smolle, M; Leitner, L; Bergovec, M; Liegl-Atzwanger, B; Stotz, M; Bezan, A; Gerger, A; Pichler, M; Kapp, KS; Stöger, H; Leithner, A; Szkandera, J Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study.
Ann Surg Oncol. 2018; 25(3):776-783 Doi: 10.1245/s10434-017-6080-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Silina, K; Leibl, S; Mündlein, A; Moch, H; Siebenhüner, A; Samaras, P; Riedl, J; Stotz, M; Szkandera, J; Stöger, H; Pichler, M; Stupp, R; van den Broek, M; Schraml, P; Gerger, A; Petrausch, U; Winder, T Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Oncoimmunology. 2018; 7(2):e1378844-e1378844 Doi: 10.1080/2162402X.2017.1378844 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Rueten-Budde, AJ; van Praag, VM; PERSARC studygroup; van de Sande, MAJ; Fiocco, M Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma.
Surg Oncol. 2018; 27(4): 695-701. Doi: 10.1016/j.suronc.2018.09.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Adiprasito, JB; Stiegelbauer, V; Seles, M; Klec, C; Pichler, GP; Resel, M; Posch, F; Lembeck, AL; Stöger, H; Szkandera, J; Pummer, K; Bauernhofer, T; Hutterer, GC; Gerger, A; Stotz, M; Pichler, M MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Int J Mol Sci. 2018; 19(10): Doi: 10.3390/ijms19103130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146 Doi: 10.1111/bjh.14912 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Balic, M; Mueller, DH; Hammer, R; Gumpoldsberger, M; Suppan, C; Posch, F; Stoeger, H; Dandachi, N; Prein, K; Hauser, H; Lax, S Independent evaluation of prognostic value of residual cancer burden (RCB) score on disease free and overall survival of breast cancer patients treated with neoadjuvant systemic treatment at a single institution
CANCER RES. 2018; 78(4):-San Antonio Breast Cancer Symposium; DEC 05-09, 2017; San Antonio, TX. [Poster]
Web of Science

 

** Grilz, E; Mauracher, LM; Konigsbrugge, O; Posch, F; Lang, I; Pabinger, I; Ay, C The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis
BLOOD. 2018; 132: Doi: 10.1182/blood-2018-99-116104
Web of Science FullText FullText_MUG

 

** Grilz, E; Posch, F; Konigsbrugge, O; Marosi, C; Pabinger, I; Ay, C Neutrophil-to-Lymphocyte Ratio and the Risk of Venous Thromboembolism and Mortality in Patients with Cancer
THROMB RES. 2018; 164: S232-S233.-9th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); APR 13-15, 2018; Bergamo, ITALY. Doi: 10.1016/j.thromres.2018.02.112 [Poster]
Web of Science FullText FullText_MUG

 

** Leithner, A; van Praag, V; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Smolle-Juttner, FM; Fiocco, M; van de Sande, M; Riedl, J; Pichler, M; Gerger, A; Szkandera, J; Stoger, H; Liegl-Atzwanger, B; Smolle, MA Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Poster]
Web of Science

 

** Mollnar, S; Pondorfer, P; Reinisch, S; Moik, F; Halm, M; Kasparek, AK; Klockl, MC; Stotz, M; Szkandera, J; Gerger, A; Vasicek, S; Weiland, T; Pichler, M; Stoger, H; Thurnher, D; Posch, F Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis
ONCOL RES TREAT. 2018; 41: 248-248. [Poster]
Web of Science

 

** Muller, HD; Posch, F; Gumpoldsberger, M; Suppan, C; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoger, H; Lax, S; Balic, M Prognostic impact of the Residual Cancer Burden (RCB) index on recurrence-free survival of breast cancer patients recieving neoadjuvant therapy
ONCOL RES TREAT. 2018; 41: 297-298. [Poster]
Web of Science

 

** Nazari, PMS; Riedl, J; Preusser, M; Posch, F; Thaler, J; Marosi, C; Birner, P; Ricken, G; Hainfellner, JA; Pabinger, I; Ay, C The combination of podoplanin expression levels and IDH1 mutation status predicts VTE risk in patients with brain tumors
THROMB RES. 2018; 164: S195-S195.-9th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); APR 13-15, 2018; Bergamo, ITALY. Doi: 10.1016/j.thromres.2018.02.038 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Rejto, J; Schuster, G; Feistritzer, C; Quehenberger, P; Posch, F; Gebhart, J; Ay, C; Pabinger, I Correlation of factor levels with bleeding phenotype in non-severe hemophilia
HAEMOPHILIA. 2018; 24: 93-93. [Poster]
Web of Science

 

** Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients
ANN ONCOL. Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany. 2018; 29(S8):-43rd ESMO Congress (ESMO); OCT 19-23, 2018; Munich, GERMANY. [Oral Communication]
Web of Science

 

Abstract (Konferenzband)

** Klöckl, MC; Kasparek, AK; Riedl, J; Moik ,F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer T; Stöger H; Posch, F Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy
Oncology Research and Treatment . 2018; 41(Suppl4):224-224.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Poster]
Web of Science FullText

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T Lymphopenia impairs response to 1st-line therapy with sunitinib and pazopanib in patients with metastatic clear-cell renal cell carcinoma.
Oncology Research and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 ) [Oral Communication]
Web of Science FullText

 

2017

Originalarbeit (Zeitschrift)

** Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Königsbrügge, O; Lorenz, M; Auinger, M; Schmaldienst, S; Klauser-Braun, R; Kletzmayr, J; Grilz, E; Posch, F; Antlanger, M; Pabinger, I; Säemann, M; Ay, C Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI).
Thromb Res. 2017; 158(8):59-64 Doi: 10.1016/j.thromres.2017.08.011
Web of Science PubMed FullText FullText_MUG

 

** Königsbrügge, O; Posch, F; Antlanger, M; Kovarik, J; Klauser-Braun, R; Kletzmayr, J; Schmaldienst, S; Auinger, M; Zuntner, G; Lorenz, M; Grilz, E; Stampfel, G; Steiner, S; Pabinger, I; Säemann, M; Ay, C Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
PLoS One. 2017; 12(1):e0169400-e0169400 Doi: 10.1371/journal.pone.0169400 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pertl, L; Mossböck, G; Wedrich, A; Weger, M; Königsbrügge, O; Silbernagel, G; Posch, F Triglycerides and Open Angle Glaucoma - A Meta-analysis with meta-regression.
Sci Rep. 2017; 7(1): 7829-7829. Doi: 10.1038/s41598-017-08295-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Gebhart, J; Rand, JH; Koder, S; Quehenberger, P; Pengo, V; Ay, C; Pabinger, I Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.
BMC Med. 2017; 15(1):54-54 Doi: 10.1186/s12916-017-0807-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, J; Preusser, M; Nazari, PM; Posch, F; Panzer, S; Marosi, C; Birner, P; Thaler, J; Brostjan, C; Lötsch, D; Berger, W; Hainfellner, JA; Pabinger, I; Ay, C Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.
Blood. 2017; 129(13):1831-1839 Doi: 10.1182/blood-2016-06-720714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061 Doi: 10.18632/oncotarget.21647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Posch, F; Pichler, GP; Gary, T; Pummer, K; Zigeuner, R; Hutterer, GC; Pichler, M Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
J Urol. 2017; 198(6):1247-1252 Doi: 10.1016/j.juro.2017.07.036
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Tunn, PU; Goldenitsch, E; Posch, F; Szkandera, J; Bergovec, M; Liegl-Atzwanger, B; Leithner, A The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre Study.
Ann Surg Oncol. 2017; 24(6):1596-1605 Doi: 10.1245/s10434-017-5776-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Willegger, M; Posch, F; Schieder, S; Funovics, PT; Scharrer, A; Brodowicz, T; Ay, C; Windhager, R; Panotopoulos, J Serum creatinine and albumin predict sarcoma-specific survival in patients with myofibroblastic and fibroblastic sarcomas.
J Orthop Res. 2017; 35(12):2815-2824 Doi: 10.1002/jor.23598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Smolle, MA; Leithner, A; Posch, F; Szkandera, J; Liegl-Atzwanger, B; Pichler, M MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review.
Int J Mol Sci. 2017; 18(9): Doi: 10.3390/ijms18091960 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Posch, F; Ay, C Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism?
Eur Respir J. 2017; 49(1): Doi: 10.1183/13993003.02225-2016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bezan, A; Pasch, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Zurl, B; Kapp, K; Stager, H; Gerger, A; Stotz, M Clinical characterization of febrile neutropenia episodes in patients with testicular germ cell tumors.
J CLIN ONCOL. 2017; 35: -53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET; JUN 02-07, 2017; Chicago, IL. Doi: 10.1200/JCO.2017.35.15_suppl.e16038 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Posch, F; Ay, C; Kreutz, R; Beyer-Westendorf, J Vitamin-K-antagonist oral anticoagulants and kidney function decline in patients with atrial fibrillation and chronic kidney disease
WIEN KLIN WOCHENSCHR. 2017; 129: S121-S121.
Web of Science

 

Kommentar

** Posch, F; Pichler, M Inflammatory Biomarkers in Diffuse Large B-Cell Lymphoma: Time for Extending the Established Prognosis Scores?
Acta Haematol. 2017; 137(2):73-75 Doi: 10.1159/000455020
Web of Science PubMed FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Hell, L; Thaler, J; Martinod, K; Ay, C; Posch, F; Wagner, DD; Pabinger, I OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?
Thromb Res. 2016; 140 Suppl 1(1):S174-S175 Doi: 10.1016/S0049-3848(16)30133-5
Web of Science PubMed FullText FullText_MUG

 

** Königsbrügge, O; Posch, F; Riedl, J; Reitter, EM; Zielinski, C; Pabinger, I; Ay, C Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
Oncologist. 2016; 21(2):252-257 Doi: 10.1634/theoncologist.2015-0284 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Panotopoulos, J; Posch, F; Funovics, PT; Willegger, M; Scharrer, A; Lamm, W; Brodowicz, T; Windhager, R; Ay, C Elevated serum creatinine and low albumin are associated with poor outcomes in patients with liposarcoma.
J Orthop Res. 2016; 34(3):533-538 Doi: 10.1002/jor.23002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Riedl, J; Reitter, EM; Kaider, A; Zielinski, C; Pabinger, I; Ay, C Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Thromb Haemost. 2016; 115(4):817-826 Doi: 10.1160/TH15-09-0758
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Thaler, J; Zlabinger, GJ; Königsbrügge, O; Koder, S; Zielinski, C; Pabinger, I; Ay, C Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Clin Cancer Res. 2016; 22(1):200-206 Doi: 10.1158/1078-0432.CCR-14-3358 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Beyer-Westendorf, J; Kreutz, R; Posch, F; Ay, C The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease
EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY. [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Stotz, M; Bezan, A; Winder, T; Schaberl-Moser, R; Pichler, M; Stoeger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw370.107 [Poster]
Web of Science FullText FullText_MUG

 

** Silina, K; Petrausch, U; Posch, F; Leibl, S; Mundlein, A; Moch, H; Siebenhuner, A; Stupp, R; Riedl, J; Pestalozzi, BC; Schraml, P; Gerger, A; Winder, T Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer
ANN ONCOL. 2016; 27: Doi: 10.1093/annonc/mdw393.12
Web of Science FullText FullText_MUG

 

** Winder, T; Posch, F; Asamer, E; Stotz, M; Siebenhuner, A; Schlick, K; Magnes, T; Samaras, P; Szkandera, J; Clavien, PA; Neureiter, D; Greil, R; Pestalozzi, BC; Stoeger, H; Gerger, A; Egle, A; Pichler, M An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer
ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK. Doi: 10.1093/annonc/mdw371.77 [Poster]
Web of Science FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Ay, C; Posch, F; Kaider, A; Zielinski, C; Pabinger, I Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.
J Thromb Haemost. 2015; 13(3):390-397 Doi: 10.1111/jth.12825 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gebhart, J; Laczkovics, C; Posch, F; Ay, C; Reitter-Pfoertner, SE; Haslacher, H; Muszbek, L; Wolberg, AS; Pabinger, I Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.
Ann Hematol. 2015; 94(8): 1301-1310. Doi: 10.1007/s00277-015-2399-7
Web of Science PubMed FullText FullText_MUG

 

** Gebhart, J; Posch, F; Koder, S; Perkmann, T; Quehenberger, P; Zoghlami, C; Ay, C; Pabinger, I Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS).
Blood. 2015; 125(22): 3477-3483. Doi: 10.1182/blood-2014-11-611129 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Panotopoulos, J; Posch, F; Alici, B; Funovics, P; Stihsen, C; Amann, G; Brodowicz, T; Windhager, R; Ay, C Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma.
J Orthop Res. 2015; 33(5): 765-770. Doi: 10.1002/jor.22827 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Posch, F; Königsbrügge, O; Zielinski, C; Pabinger, I; Ay, C Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
Thromb Res. 2015; 136(3):582-589 Doi: 10.1016/j.thromres.2015.07.011 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Originalarbeit (Zeitschrift)

** Badr Eslam, R; Posch, F; Lang, IM; Gremmel, T; Eichelberger, B; Ay, C; Panzer, S Association of thrombin generation potential with platelet PAR-1 regulation and P-selectin expression in patients on dual antiplatelet therapy.
J Cardiovasc Transl Res. 2014; 7(1):126-132 Doi: 10.1007/s12265-013-9531-7
Web of Science PubMed FullText FullText_MUG

 

** Lötsch, F; Königsbrügge, O; Posch, F; Zielinski, C; Pabinger, I; Ay, C Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
Thromb Res. 2014; 134(5): 1008-1013. Doi: 10.1016/j.thromres.2014.09.001
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Setinek, U; Flores, RM; Bernhard, D; Hannigan, GE; Mueller, MR; Watzka, SB Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study.
Clin Transl Oncol. 2014; 16(5): 455-462. Doi: 10.1007/s12094-013-1101-6
Web of Science PubMed FullText FullText_MUG

 

** Riedl, J; Posch, F; Königsbrügge, O; Lötsch, F; Reitter, EM; Eigenbauer, E; Marosi, C; Schwarzinger, I; Zielinski, C; Pabinger, I; Ay, C Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.
PLoS One. 2014; 9(10):e111440-e111440 Doi: 10.1371/journal.pone.0111440 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tibrewal, S; Malagelada, F; Jeyaseelan, L; Posch, F; Scott, G Single-stage revision for the infected total knee replacement: results from a single centre.
Bone Joint J. 2014; 96-B(6): 759-764. Doi: 10.1302/0301-620X.96B6.33086
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Pabinger, I; Posch, F Flamethrowers: blood cells and cancer thrombosis risk.
Hematology Am Soc Hematol Educ Program. 2014; 2014(1): 410-417. Doi: 10.1182/asheducation-2014.1.410 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Watzka, SB; Posch, F; Pass, HI; Flores, RM; Hannigan, GE; Bernhard, D; Weber, M; Mueller, MR Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
Eur J Cardiothorac Surg. 2013; 43(5):940-945 Doi: 10.1093/ejcts/ezs521 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Watzka, SB; Posch, F; Pass, HI; Huflejt, M; Bernhard, D; Hannigan, GE; Müller, MR Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
J Thorac Cardiovasc Surg. 2011; 142(2):384-389 Doi: 10.1016/j.jtcvs.2011.04.034 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Watzka, SB; Posch, F; Hochmair, M; Setinek, U; Köstler, WJ; Müller, MR Resistance to EGFR targeting therapies in lung cancer.
Minerva Chir. 2011; 66(5): 483-494.
Web of Science PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum